The overall 6-week mortality rate was 16%, the highest was seen in those subjects operated as an acute emergency (66%) and the lowest in those which were elective (5%). This overall rate is similar to that of Palmer's group (17.5%) for the same duration in the over 80s group. Twenty per cent of our over 90s group had serious non fatal complications such as pneumonia, myocardial infarction and cerebrovascular accident. The duration of stay of our group was longer than Palmer's at 28.7 days, compared with 19. This is reflected in the cost per patient £3020 for our group as opposed to £2000 of Palmer's at the Northern Regional average cost of £105 per day (1988/1989 figures) .
In addition we proported risk factors to our elderly patients. Those that had a previous history of diabetes, ischaemic heart disease, cerebrovascular accident, chronic obstructed airways disease or demonstrated shock on admission were considered high risk. There were 16 such patients and 34 low risk, the results are summarized below. resulted in increased mortality and, after this time, no form of therapy was clearly superior. This view was echoed by Walker et al.? who suggested a conservative policy for late diagnosis with selective surgery for septic complications and fistula persistence. Although these authors also reported a 40% leak rate following repair, their figures do not allow differentiation between those operated upon early and late.
In summary, early diagnosis must be the keystone to improved survival in this condition. Such early recognition is made possible, above all else by awareness in the clinician's mind -reliance upon clinical history, signs and simple radiography may be misleading, and contrast radiography remains the main diagnostic tool. This simple and safe investigation must be performed readily and speedily if the condition is to be diagnosed at a time when treatment has the most favourable outcome. If total hospital stay was considered then the mortality rate for the high risk group rose to 44% producing a significant difference of P=0.03 using Fisher's exact test. Like Palmer's study many of our surviving patients became dependent on institutions postoperatively particularly the semi-emergency cases. However we feel that surgery should not be withheld from patients because of their chronological age as is implied in Palmer's paper. The outcome of elective surgery in low risk subjects is surprisingly good and in high risk with adequate care patients can do well. In addition denying patients' surgery, particularly orthopaedic, can lead to protracted discomfort and nursing problems. In these cases operative treatment offers better palliation than a more conservative approach. In their last paragraph, however, they suggest that 'conservative management of Boerhaave's syndrome is now the treatment of choice'. We would challenge this statement, both on the grounds of the existing literature and from our own experience (case reports). Bladergroen and colleagues! reported that the best results were obtained (in any oesophageal perforation) with operative repair within 24 h -delay in treatment
The authors' reply below:
Recent contributors to this journal have questioned our statement that conservative management of Boerhaave's syndrome (spontaneous rupture of the oesophagus) is the treatment of choice. They have reiterated that surgery within 24 h gives an improved outcome but there is no evidence for this. All the studies quoted in recent correspondence are retrospective. In most, only a small minority are treated conservatively, usually those too sick for surgery'. This is not a fair trial of conservative management. Several studies contain very few patients with Boerhaave's syndrome, compared with other forms of oesophageal perforations-, Conclusions about the management of Boerhaave's syndrome, with its different prognosis, cannot be drawn from such heterogeneous series. Finally, the series of Lyons et al. 3 in which 13 out of 31 patients had Boerhaave's syndrome, all of those treated conservatively survived, whereas surgery had a 37% mortality. We stand by our original proposal that conservative management of Boerhaave's syndrome is the treatment of choice. A R SMYTH C WASTELL
